Stress, depression, and the role of cytokines

Advances in Experimental Medicine and Biology

Volumn 461, Issue , 1999, Pages 251-265

  Leonard, B E ^a   Song, C ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; CYTOKINE; GLUCOCORTICOID; HYDROCORTISONE; INTERLEUKIN 1; INTERLEUKIN 6; NORADRENALIN; SEROTONIN; TUMOR NECROSIS FACTOR ALPHA;

ADRENERGIC SYSTEM; CONFERENCE PAPER; DEPRESSION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOMODULATION; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; STRESS;

EID: 0033282346     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-585-37970-8_14     Document Type: Conference Paper

References (94)

1. Conditioning the immune system
2. Regulation of cytokine and cytokine receptor expression by glucocorticoids
3. The state of leucocyte adhesiveness/aggregation in the peripheral blood: A new independent marker of stress
4. The basis for amine hypothesis in affective disorder: A critical evaluation
5. Bidirectional communication between the brain and the immune system
6. Bidirectional transport of interleukin-1 alpha across the blood brain barrier
7. The immune-hypothalamic-pituitary adrenal axis
8. The acute phase response
9. Corticosteroids inhibit IL-12 production in human monocytes and enhance their capacity to induce IL-4 synthesis in CD4+ lymphocytes
10. Stress, behaviour and immunity: Animal models and mediating mechanisms
11. Hormone and neuropeptide receptors on mononuclear leucocytes
12. Glucocorticoids, stress, and the immune response
13. Depression, stress, and immunological activation: The role of cytokines in depressive disorders
14. The social-psychological pressors to cancer
15. Psychosocial factors and psychophysiological mechanism in the aetiology and development of cancers
16. Behavioural effects of peripherally injected interleukin-1: Role of prostaglandin
17. Modulation of the immune response by emotional stress
18. The challenge of Alzheimer's disease
19. Stressor-induced changes in mitogenic activity are not associated with decreased IL-2 production or changes in lymphocyte subsets
20. Interleukin 1 receptors in the brain and endocrine tissue
21. How do cytokines say hello to the brain? Neural versus humoral mediation
22. Cytokine actions on behaviour
23. Behaviourally conditioned histamine release
24. Chronic-stress and post traumatic stress disorder
25. Contrasting effects of glucocorticoids in the capacity of T cells to produce the growth factors interlukin 2 and interleukin 4
26. Glucocorticoids and the genesis of depressive illness - A psychobiological model
27. Stress mechanisms of immunosuppression
28. Evidence for the common expression of neuroendocrine hormones and cytokines in the immune and central nervous system
29. Social network interactions: A buffer or a stress?
30. Stress induced reduction in the rat mixed lymphocyte reaction is due to macrophages and not to changes in T cell phenotypes
31. Stress related impairments in cellular immunity
32. Stress depresses interferon production by leucocytes concomitant with a decrease in natural killer cell activity
33. Chronic exposure to random restraint stress retards the development of oestrogen-induced pituitary prolactinoma in rats
34. Murine tumour necrosis factor alpha is transported from blood to brain in the mouse
35. Cytokines
36. Alpha-1-acid glycoprotein in major depressive and eating disorders
37. Interleukin-1 induces anorexia in the rat
38. Cytokines in the nervous system I: Expression and recognition
39. Psychoneuroimmunology and depression
40. Depression and reduced natural killer cytotoxicity: A longitudinal study of depressed patients and control subjects
41. Interferon productions in acute psychiatric disorder
42. Suppression of immunity by stress: Effect of a gradient series of stressors on lymphocyte stimulation in the rat
43. Psychosocial modifiers of immune competence in medical students
44. Marital quality, marital disruption, and immune function
45. Methodological issue in behavioural immunology research in humans
46. Spousal caregivers of dementia victims: Longitudinal changes in immunity and health
47. Effect of intraveous injection of IL-IB on PGE2 levels in several brain areas as determined by microdialysis
48. Depression, hypothalamic pituitary adrenal cortical activity and lymphocyte function
49. Depression, HPA activity, and lymphocyte function
50. Endotoxin administration stimulates cerebral catecholamine release in hypothalamus and prefrontal cortex in freely moving rats as assessed by microdialysis
51. Stress, the immune system and mental illness
52. Stress and the immune system: Immunological aspects of depressive illness
53. Correlation of stress factors with sustained suppression of NKC activity and predicted prognosis in patients with breast cancer
54. 24 Hr profiles of ACTH, cortisol, and growth hormone in major depressed illness: Effect of AD treatment
55. Neutrophil and monocyte phagocytosis in depressed patients
56. The monocyte-T-lymphocyte hypothesis of major depression
57. Leucocytosis, monocytosis, and neutrophilia: Hallmarks of severe depression
58. Fatty acid composition in major depression: Decreased omega 3 fractions in cholesteryl esters and increased C20:4W6/C20:5W3 ratio in cholesteryl esters and phospholipids
59. Fatty acids, cytokines, and major depression
60. Psychoneuroimmunology - The interface between behaviour, brain, and immunity
61. Mortality in a follow-up to 500 psychiatric outpatients. I. Total mortality and II cause specific mortality
62. A re-evaluation of the concept of "non-specificity" in stress theory
63. Increased biogenic amine release in mouse hypothalamus following immunological challenge: Antagonism by indomethacin
64. Depression, natural killer cell activity and cortisol secretion
65. Depression, adrenal steroids, and the immune system
66. Stress-induced modulation of immune response
67. Influence of stressor predictability and behavioural control on lymphocyte reactivity, antibody response and neuroendocrine activation in rats
68. Glucocorticoids and stress: Permissive and suppressive actions
69. Secretory products of macrophages
70. Elevated concentration of CSF-CRF-like immunoreactivity in depressed patients
71. Abnormal zymosan-induced neutrophil chemiliuminescence as a marker of depression
72. Physiology and pharmacology of corticotropin releasing factor
73. Personality and risk of cancer: 20 Year follow-up of the Western Electric Study
74. Stress induced alteration of immune function
75. Regulation of the human serotonin transporter by interleukin-1 beta
76. Emotions and immunity
77. Mechanisms mediating the effects of cytokines on neuroendocrine functions in the rat
78. Interleukin in the neuroendocrine system: From gene to function
79. Depression and immunity: Lymphocyte stimulation in ambulatory depressed patients
80. Major depressive disorder: Role of age, sex, severity, and hospitalization
81. Psychological depression and 17 years risk of death from cancer
82. Stress and cancer
83. The macrophage theory of depression
84. Stress and antibody response in rats
85. Conditioned augmentation of Natural Killer Cell activity: Independence from nociceptive effects and dependence on interferon beta
86. Changes in immunoglobulin, complement and acute phase protein concentrations in depressed patients and normal controls
87. Facilitation of dimethylbenaz (a) anthracine induced rat mammory tumorigenesis by restraint stress: Role of beta endorphin, prolactin, and naltrexone
88. Depression and immunocompetence: A review of the literature
89. Induction of cytokines receptors by glucocorticoids: Functional and pathological significance
90. Glucocorticoids accelerate anti- T cell receptor induced T cell growth
91. Glucocorticoids suppress the production of interleukin 4 by human lymphocytes
92. Glucocorticoids increase the synthesis of immunoglobulin E by interleukin 4-stimulated human lymphocytes
93. TCA's inhibit IL-6, IL-1 and TNF release in human blood monocytes and IL2 and interferon in T cells